<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30167861</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>29</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>29</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1432-0851</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>67</Volume>                    <Issue>11</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Cancer immunology, immunotherapy : CII</Title>                <ISOAbbreviation>Cancer Immunol. Immunother.</ISOAbbreviation>            </Journal>            <ArticleTitle>Circulating CD8<sup>+</sup> T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients.</ArticleTitle>            <Pagination>                <MedlinePgn>1743-1752</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00262-018-2213-1</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">CD8<sup>+</sup> T cells are primarily cytotoxic cells that provide immunological protection against malignant cells. Considerable evidence suggests that the T-cell repertoire is closely associated with the host immune response and the development of cancer. In this study, we explored the characteristics of the circulating CD8<sup>+</sup> T-cell repertoire and their potential value in predicting the clinical response of breast cancer patients to chemotherapy.</AbstractText>                <AbstractText Label="EXPERIMENTAL DESIGN" NlmCategory="METHODS">We applied a high-throughput TCR β-chain sequencing method to characterize the CD8<sup>+</sup> T-cell repertoire of the peripheral blood from 26 breast cancer patients. In addition, changes in the circulating CD8<sup>+</sup> T-cell repertoire during chemotherapy were analyzed.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that the HEC ratios of the CD8<sup>+</sup> T-cell repertoires from HER2<sup>+</sup> breast cancer patients were significantly higher than those of HER2<sup>-</sup> patients, suggesting that the HER2 protein is released into circulation where it is targeted by CD8<sup>+</sup> T cells. Several Vβ and CDR3 motifs preferentially used in HER2<sup>+</sup> patients were identified. Besides, we found that the circulating CD8<sup>+</sup> T-cell repertoires evolved during chemotherapy and correlated with patient clinical responses to chemotherapy. Increased CD8<sup>+</sup> T-cell repertoire heterogeneity during chemotherapy was associated with a better clinical response.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although functional studies of clonally expanded CD8<sup>+</sup> T-cell populations are clearly required, our results suggest that the circulating CD8<sup>+</sup> T-cell repertoire reflects the characteristics of the tumor-associated biomolecules released into the blood and correlates with the clinical responses of the patients to chemotherapy which might assist in making treatment decisions.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Lin</LastName>                    <ForeName>Kai-Rong</ForeName>                    <Initials>KR</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Institute, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), NO. 81 North of Lingnan Avenue, Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pang</LastName>                    <ForeName>Dan-Mei</ForeName>                    <Initials>DM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Oncology, Cancer Center, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jin</LastName>                    <ForeName>Ya-Bin</ForeName>                    <Initials>YB</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Institute, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), NO. 81 North of Lingnan Avenue, Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hu</LastName>                    <ForeName>Qian</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Oncology, Cancer Center, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pan</LastName>                    <ForeName>Ying-Ming</ForeName>                    <Initials>YM</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Institute, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), NO. 81 North of Lingnan Avenue, Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cui</LastName>                    <ForeName>Jin-Huan</ForeName>                    <Initials>JH</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Institute, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), NO. 81 North of Lingnan Avenue, Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Xiang-Ping</ForeName>                    <Initials>XP</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Institute, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), NO. 81 North of Lingnan Avenue, Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lin</LastName>                    <ForeName>Yin-Xin</ForeName>                    <Initials>YX</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Oncology, Cancer Center, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mao</LastName>                    <ForeName>Xiao-Fan</ForeName>                    <Initials>XF</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Institute, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), NO. 81 North of Lingnan Avenue, Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Duan</LastName>                    <ForeName>Hai-Bo</ForeName>                    <Initials>HB</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Oncology, Cancer Center, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), Foshan, 528000, Guangdong, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Luo</LastName>                    <ForeName>Wei</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Research Institute, First People's Hospital of Foshan (Affiliated Foshan Hospital of Sun Yat-sen University), NO. 81 North of Lingnan Avenue, Foshan, 528000, Guangdong, China. luowei@fsyyy.com.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>81402255</GrantID>                    <Agency>National Natural Science Foundation of China</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2016A030306050</GrantID>                    <Agency>Guangdong Province Natural Science Funds for Distinguished Young Scholar</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2014A030313803</GrantID>                    <Agency>Guangdong Province Natural Science Funds</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2015AG10002</GrantID>                    <Agency>Science and Technology Innovation Platform in Foshan City</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2015TQ01R462</GrantID>                    <Agency>&quot;Guangdong Te Zhi Program&quot; youth science and technology talent project</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>22</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Germany</Country>            <MedlineTA>Cancer Immunol Immunother</MedlineTA>            <NlmUniqueID>8605732</NlmUniqueID>            <ISSNLinking>0340-7004</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D022801">Complementarity Determining Regions</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016693">Receptors, Antigen, T-Cell, alpha-beta</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="C508053">ERBB2 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>EC 2.7.10.1</RegistryNumber>                <NameOfSubstance UI="D018719">Receptor, ErbB-2</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D022801" MajorTopicYN="N">Complementarity Determining Regions</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018719" MajorTopicYN="N">Receptor, ErbB-2</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016693" MajorTopicYN="N">Receptors, Antigen, T-Cell, alpha-beta</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D017385" MajorTopicYN="N">Sequence Homology</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">CD8+ T-cell repertoire</Keyword>            <Keyword MajorTopicYN="N">Clinical response</Keyword>            <Keyword MajorTopicYN="N">HER2 expression status</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30167861</ArticleId>            <ArticleId IdType="doi">10.1007/s00262-018-2213-1</ArticleId>            <ArticleId IdType="pii">10.1007/s00262-018-2213-1</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>